Organigram Shares Rise 29% After Investment By BAT Subsidiary
By Chris Wack
Organigram Holdings shares were up 29% at $1.50 after a C$124.6 million ($91.1 million) follow-on strategic equity investment from BT DE Investments, a wholly owned subsidiary of BAT.
The stock hit its 52-week low of 97 cents on Oct. 27, and is down 61% in the past 12 months.
Organigram said the investment will allow it to deliver on its stated ambition to extend its footprint beyond Canada, as well as strengthen its financial position for long-term, sustainable growth.
The company will be able to invest in improving its core business, while improving operations to deliver on cost-saving efficiencies, accelerating earnings growth.
The majority of the investment will be used to create a strategic investment pool, named Jupiter, which will target investments in emerging cannabis opportunities that will enable Organigram to apply its industry-leading capabilities to new markets.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
November 06, 2023 10:25 ET (15:25 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Markets Brief: Non-Farm Payrolls in the Spotlight Again
-
6 Top-Performing Large-Growth Funds
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
Morningstar’s Guide to Investing in Stocks
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst